News and Events

12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release

10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here

10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies

LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie restriction
1/25/2009 Link to story and video

LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS ONE

Latest News
girl

Thomas T Dope

Thomas T Dope Ph.D.
Director and Co-founder

Dr. Thomas T. Dope got his B.S in Biochemistry from the University of Texas at Austin in 1989 and his Ph.D from the Department of Molecular Biophysics and Biochemistry at Harvard University in 1992. He is engaged in the medical genetics at the University of Wisconsin. Dr. Dope’s scientific team was the first to employ large-scale gene expression profiling using DNA microarrays. They are used as the analysis of aging and its retardation by caloric restriction.

Copyright © 2022, www.lifegentech.com. All rights reserved. Site Map | Legal | Contact